About the Company
We do not have any company description for Elevation Oncology, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Elevation Oncology, Inc.
Elevation Oncology Enters into Agreement to Be Acquired by ... - KTLA
BOSTON, June 9, 2025 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat ...
Elevation Oncology, Inc. (NASDAQ:ELEV) Receives Average Recommendation ...
Elevation Oncology has a 1-year low of $0.22 and a 1-year high of $4.33. The firm has a market cap of $19.69 million, a price-to-earnings ratio of -0.41 and a beta of 1.59.
Elevation Oncology Enters into Agreement to Be Acquired by Concentra ...
BOSTON, June 9, 2025 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients ...
Elevation Oncology, Inc. (NASDAQ:ELEV) Given Consensus Rating of “Buy ...
Elevation Oncology, Inc, an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.
Elevation Oncology Announces Pricing of $50 Million Public Offering
--Elevation Oncology, Inc., an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant ...
Elevation Oncology Enters into Agreement to Be Acquired by Concentra ...
BOSTON, June 9, 2025 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat ...
Elevation Oncology Inc. Advanced Charts | ELEV | Barron's
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations.
Elevation Oncology Inc. Company & People | ELEV | Barron's
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations.
Similar Companies
Loading the latest forecasts...